Endoluten

Endoluten is a peptide bioregulator developed within Professor Vladimir Khavinson's research program, derived from the neuroendocrine complex (pineal gland and hypothalamus) of young animals. Unlike Epithalon, which is a defined tetrapeptide (Ala-Glu-Asp-Gly), Endoluten is a more complex preparation containing a mixture of short regulatory peptides from neuroendocrine tissue, similar in approach to thymic peptide preparations like Thymalin.

The neuroendocrine system is considered a primary regulator of aging pace in Khavinson's theoretical framework. As the pineal gland and hypothalamic nuclei age, their ability to maintain coordinated hormonal signaling — particularly melatonin synthesis, circadian rhythm entrainment, and hypothalamic-pituitary axis coordination — declines. This contributes to the desynchronization of hormonal rhythms (sleep-wake, cortisol, sex hormone cycles) observed in aging.

Endoluten is proposed to deliver short regulatory peptides that can restore gene expression in the pineal and hypothalamic tissue to a more youthful pattern, complementing the telomere biology approach of Epithalon (which activates telomerase in pineal tissue via its tetrapeptide sequence).

Clinical studies from the Khavinson group (published in journals including the Bulletin of Experimental Biology and Medicine, Russian Gerontology, and Advances in Gerontology) have reported improvements in sleep quality, hormonal rhythm markers, and cognitive function scores in elderly subjects treated with neuroendocrine bioregulator protocols. These studies were primarily conducted in Russian clinical research settings and have not been extensively replicated internationally.